1,108 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by Founders Capital Management LLC

Founders Capital Management LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,108 shares of the healthcare conglomerate’s stock, valued at approximately $205,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. State Street Corp boosted its position in UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after buying an additional 1,122,534 shares in the last quarter. Legal & General Group Plc boosted its position in UnitedHealth Group by 5.4% in the first quarter. Legal & General Group Plc now owns 4,954,692 shares of the healthcare conglomerate’s stock worth $812,630,000 after buying an additional 254,545 shares in the last quarter. Harris Associates L P boosted its position in UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock worth $762,041,000 after buying an additional 14,489 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in UnitedHealth Group by 6.2% in the first quarter. UBS Asset Management Americas Inc. now owns 4,372,898 shares of the healthcare conglomerate’s stock worth $717,199,000 after buying an additional 255,799 shares in the last quarter. Finally, American Century Companies Inc. boosted its position in UnitedHealth Group by 9.0% in the first quarter. American Century Companies Inc. now owns 4,022,002 shares of the healthcare conglomerate’s stock worth $659,649,000 after buying an additional 333,338 shares in the last quarter. 86.37% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Incorporated (NYSE:UNH) traded down 1.25% during trading on Thursday, hitting $192.40. The company had a trading volume of 925,870 shares. The stock has a market capitalization of $186.02 billion, a price-to-earnings ratio of 23.11 and a beta of 0.64. The firm’s 50 day moving average is $188.96 and its 200-day moving average is $174.38. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same period in the previous year, the company earned $1.96 earnings per share. UnitedHealth Group’s quarterly revenue was up 7.7% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

WARNING: “1,108 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by Founders Capital Management LLC” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright legislation. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/2798864/1108-shares-in-unitedhealth-group-incorporated-nyseunh-acquired-by-founders-capital-management-llc.html.

UNH has been the topic of a number of analyst reports. Morgan Stanley upped their target price on UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, June 28th. Deutsche Bank AG reiterated a “buy” rating and issued a $187.00 price target (up previously from $183.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein reiterated an “outperform” rating and issued a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $205.00 price target (up previously from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, May 19th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $200.24.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,540 shares of company stock valued at $2,873,320. 0.89% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.